Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n -butyl-cyanoacrylate

Abstract

Objectives

To evaluate the safety and efficacy of ethylene vinyl alcohol copolymer (EVOH) injection for selective occlusion of portal branches considered at risk for non-target embolisation during preoperative portal vein embolisation (PVE).

Methods

Twenty-nine patients (mean age, 57 ± 17 years) submitted to PVE with n-butyl-cyanoacrylate (NBCA) and additional EVOH for selected portal branches were retrospectively analysed. Indications for the use of EVOH and the selected portal branches were evaluated. Degree of hypertrophy of the future liver remnant (FLR) and kinetic growth were assessed by CT volumetry performed before and 3–6 weeks after PVE. Clinical outcome and histopathological analysis of portal veins occluded with EVOH were reviewed.

Results

EVOH was indicated intraoperatively for embolisation of selected portal branches that the operator reported at risk to provoke non-target embolisation with NBCA. Indications for the use of EVOH were embolisation of segment IV (n = 21), embolisation of segmental portal branches with early bifurcation (n = 7) and PVE in a 1-year-old girl with cystic hamartomas. All targeted portal branches were successfully embolised. There were no cases with non-target embolisation by EVOH. The degree of hypertrophy of the FLR was 14.3 ± 8.1% and the kinetic growth rate was 2.7 ± 1.8% per week.

Conclusion

EVOH is safe and effective for embolisation of selected portal vein branches considered at risk for non-target embolisation.

Key Points

• EVOH is another effective liquid embolic agent for preoperative PVE.

• EVOH is relatively simple to handle with a minimal risk of non-target embolisation.

• During PVE, some portal branches considered complicated to occlude with NBCA may be efficiently embolised with EVOH.